The short version of Ac-LKKTETQ fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-26 and is reviewed periodically as new material appears.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
Proposed activity centers on actin sequestration and on the movement of cells during repair processes. In cell culture and animal models, the fragment has been associated with migration, tube formation, and tissue remodeling. These observations are frequently described as preliminary, because most published work uses rodent or in vitro systems rather than controlled human trials. Whether the short fragment reproduces the effects of the full protein remains an open question, and the relationship between dose, route, and measured outcome is not well characterized.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
Member Natl. Acad. Sci. USA. Yuri Ovchinnikov (1934–1988). Soviet biochemist at Moscow State University and the Protein Institute of the Academy of Sciences of the Soviet Union known for research on rhodopsin and structural biology. Full member of the Academy of Sciences of the Soviet Union.
On 15 September 2024, Bukele stated that his 2025 government budget would not include "a single cent of debt for current spending" ("solo centavo de deuda para gasto corriente") and that his government would not take out foreign loans to pay for the budget. On 16 October, El Salvador and J.P. Morgan & Co. agreed to restructure US$1.03 billion of the country's debt as a part of a debt-for-nature swap, which Bukele described as "reaffirm[ing] this government's commitment to economic growth". In the agreement, El Salvador would allocate US$352 million in savings towards conserving the environment around the Lempa River. On three occasions in 2024, Bukele offered to buy back billions of dollars worth of government bonds due by 2034. In November 2024, the Central American Bank for Economic Integration announced that it would give the Salvadoran government $646 million to finance infrastructure projects. Bukele stated that the bank's support would help El Salvador's "economic takeoff" ("despegue económico"). Later that month, Bukele wrote on X that he supported mining gold, describing it as "wealth that could transform El Salvador". He further described the country's metal mining ban as "absurd". The Catholic Church, which supported the mining ban's implementation in 2017, called on Bukele to not repeal the ban, citing environmental concerns. The Legislative Assembly repealed the ban on 23 December 2024 and Bukele approved the law that same day.
=== Acute === Acute exposure to cadmium fumes may cause flu-like symptoms including chills, fever, and muscle ache sometimes referred to as "the cadmium blues." Symptoms may resolve after a week if there is no respiratory damage. More severe exposures can cause tracheobronchitis, pneumonitis, and pulmonary edema. Symptoms of inflammation may start hours after the exposure and include cough, dryness and irritation of the nose and throat, headache, dizziness, weakness, fever, chills, and chest pain.
Sources: en.wikipedia.org
The team of inventors Edison employed at his laboratories in Menlo Park, New Jersey did, however, develop the first practical light bulb in 1880 (employing a carbonized bamboo filament), shortly prior to Joseph Swan, who invented an even more efficient bulb in 1881 (which used a cellulose filament). Henry Ford did not invent either the automobile or the assembly line. He did improve the assembly line process substantially, sometimes through his own engineering but more often through sponsoring the work of his employees, and he was the main person behind the introduction of the Model T, regarded as the first affordable automobile. Karl Benz (co-founder of Mercedes-Benz) is credited with the invention of the first modern automobile, and the assembly line has existed throughout history. Al Gore never said that he had "invented" the Internet. What Gore actually said was, "During my service in the United States Congress, I took the initiative in creating the Internet", in reference to his political work towards developing the Internet for widespread public use. Gore was the original drafter of the High Performance Computing and Communication Act of 1991, which provided significant funding for supercomputing centers, and this in turn led to upgrades of a major part of the already-existing early 1990s Internet backbone, the NSFNet, and development of NCSA Mosaic, the browser that popularized the World Wide Web.
=== Imaging === Medical imaging may provide a limited amount of information regarding bone marrow. Plain film x-rays pass through soft tissues such as marrow and do not provide visualization, although any changes in the structure of the associated bone may be detected. CT imaging has somewhat better capacity for assessing the marrow cavity of bones, although with low sensitivity and specificity. For example, normal fatty "yellow" marrow in adult long bones is of low density (-30 to -100 Hounsfield units), between subcutaneous fat and soft tissue. Tissue with increased cellular composition, such as normal "red" marrow or cancer cells within the medullary cavity will measure variably higher in density. MRI is more sensitive and specific for assessing bone composition. MRI enables assessment of the average molecular composition of soft tissues and thus provides information regarding the relative fat content of marrow. In adult humans, "yellow" fatty marrow is the dominant tissue in bones, particularly in the (peripheral) appendicular skeleton. Because fat molecules have a high T1-relaxivity, T1-weighted imaging sequences show "yellow" fatty marrow as bright (hyperintense). Furthermore, normal fatty marrow loses signal on fat-saturation sequences, in a similar pattern to subcutaneous fat. When "yellow" fatty marrow becomes replaced by tissue with more cellular composition, this change is apparent as decreased brightness on T1-weighted sequences.
== History == The discovery of coordination polymers, or as later termed metal-organic frameworks, was a logical continuation of research on post-zeolite materials. In 1989 Richard Robson reported the first organic copper-based coordination network by complexation of anions with tetrahedral bridging ligands. Similar copper(I) coordination polymers have been synthesized in 1992 by Susumu Kitagawa, which contained pores with loosely bound acetone molecules, but the structure would collapse upon their removal. Further efforts were devoted to develop extended 3D porous networks that would be stable upon removal of guest molecule and would exhibit permanent porosity. In 1995, Omar M. Yaghi demonstrated interpenetrated 2-D structure with carboxylate-based linkers that remained stable upon guest removal and could re-adsorb specific aromatic molecules. Permanent porosity in 3-D coordination polymer was first demonstrated in 1997 by Susumu Kitagawa. A year later, Yaghi proposed a new synthetical concept that employs secondary building units (SBUs) — metal-carboxylate clusters that serve as rigid building blocks for constructing frameworks with permanent porosity. In 1999, Yaghi and colleagues used SBU approach to synthesize MOF-5 that consists of zinc oxide clusters and terephthalate linkers. MOF-5 exhibits strong bonds between metal centers and coordinating organic molecules and hence exhibits high thermal stability while maintaining high porosity..
Sources: en.wikipedia.org
Arterial embalming, which involves the injection of embalming chemicals into the blood vessels, usually via the right common carotid artery. Blood and interstitial fluids are displaced by this injection and, along with excess arterial solution, are expelled from the right jugular vein and collectively referred to as drainage. The embalming solution is injected with a centrifugal pump, and the embalmer massages the body to break up circulatory clots so as to ensure the proper distribution of the embalming solution. This process of raising vessels with injection and drainage from a solitary location is known as a single-point injection. In cases of poor circulation of the arterial solution, additional injection points (commonly the axillary, brachial, or femoral arteries, with the ulnar, radial, and tibial vessels if necessary) are used. Cases where more than one vessel is raised are referred to as multi-point injection, with a reference to the number of vessels raised (i.e. a six-point injection or six-pointer). As a general rule, the more points needing to be raised, the greater the difficulty of the case. In some cases draining from a different site from injection (i.e. injecting arterial fluid into the right common carotid artery and draining from the right femoral vein) is referred to as a split (or sometimes cut) injection. In certain cases the embalmer may deem it necessary to perform a restricted cervical injection, which involves injecting the head of the deceased separately from the rest of body.
=== Liquid properties tuner === The inclusion of nanoparticles in a solid or liquid medium can substantially change its mechanical properties, such as elasticity, plasticity, viscosity, compressibility.
== What does it deliver? == DNA extraction is frequently a preliminary step in many diagnostic procedures used to identify environmental viruses and bacteria and diagnose illnesses and hereditary diseases. These methods consist of, but are not limited to: Fluorescence In Situ Hybridization (FISH) technique was developed in the 1980s. The basic idea is to use a nucleic acid probe to hybridize nuclear DNA from either interphase cells or metaphase chromosomes attached to a microscopic slide. It is a molecular method used, among other things, to recognize and count particular bacterial groupings. To recognize, define, and quantify the geographical and temporal patterns in marine bacterioplankton communities, researchers employ a technique called terminal restriction fragment length polymorphism (T-RFLP). Sequencing: Whole or partial genomes and other chromosomal components, ended for comparison with previously published sequences.
vacuum flask Also Dewar flask or thermos. A storage vessel consisting of two flasks or other containers, placed one within the other and joined at the neck, and a space in between that is partially evacuated of air, creating a near-vacuum that significantly reduces the transfer of heat between the vessel's interior and its ambient environment. Vacuum flasks can greatly lengthen the time over which their contents remain warmer or cooler than the ambient environment.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.